Literature DB >> 18570702

Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Abesh K Bhattacharjee1, Lisa Chang, Mei Chen, Laura White, Jane M Bell, Richard P Bazinet, Stanley I Rapoport.   

Abstract

Acute d-amphetamine (d-Amph) administration to rats leads to the release of arachidonic acid (AA, 20:4n-6) as a second messenger following indirect agonism at dopamine D2-like receptors in the brain. We hypothesized that chronically administered d-Amph in rats also would alter brain AA metabolism and signalling. To test this, adult male rats were injected i.p. daily for 2 wk with saline or 2.5 mg/kg d-Amph. After a 1-d washout, the unanaesthetized rats were injected acutely with i.v. saline, 1 mg/kg quinpirole (a D2-like receptor agonist) or 5.0 mg/kg SKF-38393 (a D1-like receptor agonist), followed by i.v. [1-14C]AA. The AA incorporation coefficient k* (brain radioactivity/integrated plasma radioactivity), a marker of AA signalling and metabolism, was quantified using autoradiography in each of 62 brain regions. Compared with chronic saline, chronic d-Amph widely decreased baseline values of k* in brain regions having D2-like receptors. On the other hand, chronic amphetamine did not alter the k* responses to quinpirole seen in chronic saline-treated rats. SKF-38393 had minimal effects on k* in both chronic saline-treated and amphetamine-treated rats, consistent with D1-like receptors not being coupled to AA signalling. The ability of chronic d-Amph after 1-d washout to down-regulate baseline values of k* probably reflects neuroplastic changes in brain AA signalling, and may correspond to depressive behaviours noted following withdrawal from chronic amphetamine in humans and in rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570702      PMCID: PMC2676692          DOI: 10.1017/S1461145708008833

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  71 in total

1.  Cerebral decortication reverses the effect of amphetamine on striatal D2 dopamine binding site density.

Authors:  H A Robertson
Journal:  Neurosci Lett       Date:  1986-12-23       Impact factor: 3.046

2.  Quantitative analysis of simple lipid classes by thin-layer chromatography.

Authors:  V P Skipski; J J Good; M Barclay; R B Reggio
Journal:  Biochim Biophys Acta       Date:  1968-01-10

3.  Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography.

Authors:  Giuseppe Esposito; Giampiero Giovacchini; Margaret Der; Jeih-San Liow; Abesh K Bhattacharjee; Kaizong Ma; Peter Herscovitch; Michael Channing; William C Eckelman; Mark Hallett; Richard E Carson; Stanley I Rapoport
Journal:  Neuroimage       Date:  2006-12-29       Impact factor: 6.556

4.  Brain palmitate incorporation in awake and anesthetized rats.

Authors:  A S Kimes; D Sweeney; S I Rapoport
Journal:  Brain Res       Date:  1985-08-19       Impact factor: 3.252

5.  Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat.

Authors:  Ho-Joo Lee; Jagadeesh S Rao; Lisa Chang; Stanley I Rapoport; Richard P Bazinet
Journal:  J Lipid Res       Date:  2007-10-23       Impact factor: 5.922

Review 6.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

7.  Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation.

Authors:  Mireille Basselin; Nelly E Villacreses; Ho-Joo Lee; Jane M Bell; Stanley I Rapoport
Journal:  J Neurochem       Date:  2007-05-04       Impact factor: 5.372

8.  Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction.

Authors:  Giampiero Giovacchini; Alicja Lerner; Maria T Toczek; Charles Fraser; Kaizong Ma; James C DeMar; Peter Herscovitch; William C Eckelman; Stanley I Rapoport; Richard E Carson
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

Review 9.  Dopamine and drug addiction: the nucleus accumbens shell connection.

Authors:  Gaetano Di Chiara; Valentina Bassareo; Sandro Fenu; Maria Antonietta De Luca; Liliana Spina; Cristina Cadoni; Elio Acquas; Ezio Carboni; Valentina Valentini; Daniele Lecca
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

10.  Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.

Authors:  Jagadeesh S Rao; Renee N Ertley; Stanley I Rapoport; Richard P Bazinet; Ho-Joo Lee
Journal:  J Neurochem       Date:  2007-05-10       Impact factor: 5.372

View more
  4 in total

1.  The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.

Authors:  Madhav Thambisetty; Kathy A Gallardo; Jeih-San Liow; Lori L Beason-Held; John C Umhau; Abesh K Bhattacharjee; Margaret Der; Peter Herscovitch; Judith L Rapoport; Stanley I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

2.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

Review 3.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Authors:  Mireille Basselin; Epolia Ramadan; Stanley I Rapoport
Journal:  Brain Res Bull       Date:  2011-12-09       Impact factor: 4.077

4.  Na+,K+-ATPase activity in an animal model of mania.

Authors:  Alexandra I Zugno; Samira S Valvassori; Emilene B S Scherer; Cristiane Mattos; Cristiane Matté; Camila L Ferreira; Gislaine T Rezin; Angela T S Wyse; João Quevedo; Emilio L Streck
Journal:  J Neural Transm (Vienna)       Date:  2009-03-03       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.